How is Acalabrutinib dosed?
The dosage of acalabrutinib is determined based on the individual patient's condition, medical history, and response to the treatment. The recommended dosage can vary depending on the specific indication being treated (mantle cell lymphoma, chronic lymphocytic leukemia, or small lymphocytic lymphoma). It is important to follow the dosage instructions provided by your healthcare professional and to take the medication as prescribed. Please refer to the patient information leaflet for detailed instructions.
What is the dosage form of Acalabrutinib?
Acalabrutinib is available in the form of oral tablets.
How is Acalabrutinib administered?
Acalabrutinib is administered orally as a capsule or tablet. It should be taken with a glass of water. Do not open, dissolve, crush, break, or chew the capsule. You may take this medicine with or without food, but if you are using an antacid (such as calcium carbonate), you should take it at least 2 hours before or after using the capsule. It is important to carefully follow the instructions provided by your doctor and the patient information leaflet. Consult your healthcare professional for proper usage and potential drug interactions.
What are common precautions when taking Acalabrutinib?
When taking acalabrutinib orally, it is important to take precautions such as avoiding close contact with people who are sick or have infections, washing hands frequently, staying away from rough sports or situations that could cause injury, being cautious when using sharp objects, avoiding sun exposure, and using sunscreen when necessary. It is also important to monitor for side effects such as constipation, diarrhea, difficulty moving, joint pain, muscle cramps, nausea, rash, and stomach pain.